Evidence map›Paper›PMID 41241761›Full record

ReviewAsia-Pacific journal of clinical oncology2026

The Increasing Importance of Breast Cancer in the United Arab Emirates.

Ruqaiyyah Siddiqui, Shaikha Alagroobi Alsuwaidi, Oktay Irkorucu, Malik Hassan Mehmood, Naveed Ahmed Khan

Registry-linked trialAbstract readReview
In one paragraph

Review in Asia-Pacific journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07293052 (Comparison of Outcome Between Grisotti Flap Versus Reverse Mirror Grisotti Flap for Central Quadrant Breast Tumors), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07293052 naactive not recruitingnot on this map

Comparison of Outcome Between Grisotti Flap Versus Reverse Mirror Grisotti Flap for Central Quadrant Breast Tumors

TypeinterventionalSponsorMayo Hospital LahoreRan2025 to 2026Enrolled106ConditionsBreast Cancer, Breast ReconstructionArmsGrisotti Flap, Reverse Mirror Grisotti Flap
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruqaiyyah SiddiquiInstitute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, UK.
Shaikha Alagroobi AlsuwaidiCollege of Arts and Sciences, American University of Sharjah, Sharjah, UAE.
Oktay IrkorucuCollege of Medicine, University of Sharjah, Sharjah, UAE.
Malik Hassan MehmoodDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan.
Naveed Ahmed KhanMicrobiota Research Center, Istinye University, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-7667-8553

Funding

The Air Force Office of Scientific Research, USA
6 · The paper itself

Abstract

Breast cancer is a ubiquitous health problem in the world, and recent studies point toward an increase in breast cancer incidence in the Middle East. The prevalence of breast cancer in the United Arab Emirates (UAE) has evidently increased dramatically throughout the decades, making breast cancer one of the most prevalent types of cancer. In addition, breast cancer is alarmingly being diagnosed at an earlier age, almost a decade younger in the UAE compared to Western regions. Several causative risk factors may be attributed to this increase, such as obesity caused by a developing sedentary lifestyle and consuming a high-caloric diet, genetic factors, and other relevant issues, including limited knowledge and awareness regarding breast cancer, low participation levels in breast cancer examinations, and lack of medical insurance coverage. Herein, we discuss the incidence of breast cancer, screening, risk factors, treatment, and cancer registry in the UAE. We also deliberate current advances in breast cancer diagnosis and treatment in the UAE, as well as relate breast cancer in the UAE with other Middle Eastern countries, such as Saudi Arabia, Kuwait, and Oman. Future clinical trials with a focus on the local population are encouraged, along with the establishment of a clinical trials unit that has a focus on cancer and breast cancer in particular, within the region.

Indexed as

Breast NeoplasmsFemaleHumansIncidenceRisk FactorsUnited Arab EmiratescancerprognosisUAE

Identifiers

PMID41241761
PMCPMC13569025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.